HER2 Positive Gastric Cancer Recruiting Phase 1 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0076824 (HER2 Positive Gastric Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03319459FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsTreatment